416 related articles for article (PubMed ID: 33396266)
1. The Role of CDK5 in Tumours and Tumour Microenvironments.
Do PA; Lee CH
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33396266
[TBL] [Abstract][Full Text] [Related]
2. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
[TBL] [Abstract][Full Text] [Related]
3. A kinase of many talents: non-neuronal functions of CDK5 in development and disease.
Sharma S; Sicinski P
Open Biol; 2020 Jan; 10(1):190287. PubMed ID: 31910742
[TBL] [Abstract][Full Text] [Related]
4. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
Maccioni RB; Otth C; Concha II; Muñoz JP
Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
[TBL] [Abstract][Full Text] [Related]
5. Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5.
Sharma MR; Tuszynski GP; Sharma MC
J Cell Biochem; 2004 Feb; 91(2):398-409. PubMed ID: 14743398
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators.
Tang D; Wang JH
Prog Cell Cycle Res; 1996; 2():205-16. PubMed ID: 9552397
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
[TBL] [Abstract][Full Text] [Related]
8. Post-translational modifications of CDK5 and their biological roles in cancer.
Gao GB; Sun Y; Fang RD; Wang Y; Wang Y; He QY
Mol Biomed; 2021 Jul; 2(1):22. PubMed ID: 35006426
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Mechanisms Mediated by CDK5 Inhibition.
Mushtaq G; Greig NH; Anwar F; Al-Abbasi FA; Zamzami MA; Al-Talhi HA; Kamal MA
Curr Pharm Des; 2016; 22(5):527-34. PubMed ID: 26601962
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of a splice variant of collapsin response mediator protein 2 in the nucleus of tumour cells links cyclin dependent kinase-5 to oncogenesis.
Grant NJ; Coates PJ; Woods YL; Bray SE; Morrice NA; Hastie CJ; Lamont DJ; Carey FA; Sutherland C
BMC Cancer; 2015 Nov; 15():885. PubMed ID: 26555036
[TBL] [Abstract][Full Text] [Related]
11. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
[TBL] [Abstract][Full Text] [Related]
12. CDK5-mediated tau accumulation triggers methamphetamine-induced neuronal apoptosis via endoplasmic reticulum-associated degradation pathway.
Xiao N; Zhang F; Zhu B; Liu C; Lin Z; Wang H; Xie WB
Toxicol Lett; 2018 Aug; 292():97-107. PubMed ID: 29705343
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase 5 influences Rohon-Beard neuron survival in zebrafish.
Kanungo J; Li BS; Zheng Y; Pant HC
J Neurochem; 2006 Oct; 99(1):251-9. PubMed ID: 16911583
[TBL] [Abstract][Full Text] [Related]
14. Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5.
Arif A
Biochem Pharmacol; 2012 Oct; 84(8):985-93. PubMed ID: 22795893
[TBL] [Abstract][Full Text] [Related]
15. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
16. Regulation and role of cyclin-dependent kinase activity in neuronal survival and death.
Hisanaga S; Endo R
J Neurochem; 2010 Dec; 115(6):1309-21. PubMed ID: 21044075
[TBL] [Abstract][Full Text] [Related]
17. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
Schmid G; Strosznajder JB; Wesierska-Gadek J
Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520
[TBL] [Abstract][Full Text] [Related]
18. S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development.
Zhang P; Yu PC; Tsang AH; Chen Y; Fu AK; Fu WY; Chung KK; Ip NY
J Neurosci; 2010 Oct; 30(43):14366-70. PubMed ID: 20980593
[TBL] [Abstract][Full Text] [Related]
19. Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications.
Oner M; Lin E; Chen MC; Hsu FN; Shazzad Hossain Prince GM; Chiu KY; Teng CJ; Yang TY; Wang HY; Yue CH; Yu CH; Lai CH; Hsieh JT; Lin H
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395805
[TBL] [Abstract][Full Text] [Related]
20. CDK4 and CDK5 Inhibition Have Comparable Mild Hypothermia Effects in Preventing Drp1-Dependent Mitochondrial Fission and Neuron Death Induced by MPP
Yang SH; Huang CY; Hsieh CY; Chuang JI
Mol Neurobiol; 2020 Oct; 57(10):4090-4105. PubMed ID: 32666227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
